Spain gives go ahead to research using therapeutic cloning
By Typically Spanish,
Typically Spanish
| 01. 24. 2008
The Spanish Commission for the Control of the Donation and Use of Human Stem Cells, a body which depends on the Ministry for Health and Consumer Affairs, has given the green light to the first project in Spain which will use the technique known as nucleus transfer. This is therapeutic cloning to obtain lines of stem cells which are prepared specifically from the patient.
The research is led by Miodrag Stojkovic at the Centro Prínciple Felipe de Valencia, and is intended to investigate the molecular bases of two neurological illnesses, child epilepsy and hereditary palsy. Stojkovic was the first European scientist who managed to clone a human embryo from embryonic stem cells.
The Ministry for Health has also given its support to two other studies, one in Valencia and another in Madrid, but the final approval still has to be obtained from the regional governments in each region.
Related Articles
By Kristine Servando, Bloomberg | 12.05.2024
(Bloomberg) — A woman in Hong Kong had to travel to two different countries to attempt conceiving a baby on her own. A gay couple in the city resorted to even bigger extremes: Banned from surrogacy, they turned to the...
By Sarojini Nadimpally and Gargi Mishra, The Wire | 12.15.2024
In-vitro fertilisation (IVF) as assisted reproductive technology (ART) has been in vogue for quite a few decades now. While IVF has been hailed as a significant scientific advancement, with many advantages, here are some limitations which bear keeping in mind...
By Stefan Bernhardt-Radu, Aeon | 12.02.2024
In the 18th century, European scholars began to envision a more enlightened world in harmony with nature. The old aristocratic regime, some hoped, would soon be replaced by a progressive society in which moral and social values were aligned with...
By Natalie Obiko Pearson, Jessica Brice, Susan Berfield, Vernon Silver, Kanoko Matsuyama, Cindy Wang, Sinduja Rangarajan, Fani Nikiforaki, Bloomberg | 12.12.2024
A single cell.
A global business worth billions.
A trade that can bring rewards—or human costs that cannot be measured.
The human egg is a precious resource, exchanged in markets open, gray or black. To tell its story, we follow...